{
    "clinical_study": {
        "@rank": "104046", 
        "acronym": "EURO KLEAR", 
        "arm_group": {
            "arm_group_label": "Celotres", 
            "arm_group_type": "Other", 
            "description": "Celotres following surgical removal of earlobe keloid."
        }, 
        "brief_summary": {
            "textblock": "The objective of the study is to actively gather additional information on safety, device\n      performance and possible emergent risks following the use of Celotres in a post-market\n      setting when used to reduce the recurrence rate, volume, appearance and/or symptoms\n      associated with keloid scarring in subjects undergoing surgical excision of keloids as\n      compared to the scientific literature."
        }, 
        "brief_title": "A Post Market Study Evaluating the Safety, Device Perfomance and Possible Emergent Risks of Celotres in Preventing Recurrence in Keloid Lesions Treated Adjunctive to Surgical Excision", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Actual"
        }, 
        "condition": "Earlobe Keloids", 
        "condition_browse": {
            "mesh_term": [
                "Keloid", 
                "Recurrence"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients electing to undergo keloid excision procedure\n\n          -  Patients able and willing to give written informed consent\n\n        Exclusion Criteria:\n\n          -  Patients with a known or potential risk of allergy or sensitivity to products or\n             substances containing porcine gelatin."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "51", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01706861", 
            "org_study_id": "HAL-302"
        }, 
        "intervention": {
            "arm_group_label": "Celotres", 
            "description": "Celotres following surgical removal of earlobe keloid.", 
            "intervention_name": "Celotres", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 24, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Nassau", 
                        "country": "Bahamas"
                    }, 
                    "name": "University of the West Indies"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Katowice", 
                        "country": "Poland"
                    }, 
                    "name": "Angelius Szpital Proviat"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Krakow", 
                        "country": "Poland"
                    }, 
                    "name": "Oddzial Leczenia Oparzen Chirugil Plastysznej"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warsaw", 
                        "country": "Poland"
                    }, 
                    "name": "Wojskowy Oddzial Kliniczny ChirurgiiPlastycznej"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warsaw", 
                        "country": "Poland"
                    }, 
                    "name": "Kosmetyczno-Lekarska Sp\u00f3\u0142dzielnia Pracy \"IZIS\""
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edgbaston", 
                        "country": "United Kingdom", 
                        "state": "Birmingham", 
                        "zip": "B15 3SJ"
                    }, 
                    "name": "The Westbourne Centre"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Bahamas", 
                "Poland", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "A Post Market Study Evaluating the Safety, Device Perfomance and Possible Emergent Risks of Celotres in Preventing Recurrence in Keloid LEsions Treated Adjunctive to suRgical Excision. PMCS: EURO-KLEAR", 
        "overall_official": {
            "affiliation": "The Westbourne Centre", 
            "last_name": "Sam Bella, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United Kingdom: National Health Services", 
                "Poland:  Ethic  Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Device safety is defined as the incidence of device related adverse events.", 
                "measure": "The incidence of device related adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Assessed at treatment, suture removal, Months 1, 3, 6, 9 and 12"
            }, 
            {
                "description": "Proportion of subjects with recurrence of keloid scar post excision defined as the presence of scar tissue volume >0.3cc", 
                "measure": "Recurrence of keloid post scar excision", 
                "safety_issue": "No", 
                "time_frame": "Assessed at 1, 3, 6, 9 and 12 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01706861"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Patient and Observer Scar Assessment Scale (POSAS)", 
                "safety_issue": "No", 
                "time_frame": "Assessed at Pre-treatment, Months 1, 3, 6, 9 and 12"
            }, 
            {
                "measure": "Subject Dermatology Life Quality Index (DLQI)", 
                "safety_issue": "No", 
                "time_frame": "Assessed at Pre-treatment, Months 1, 3, 6, 9 and 12"
            }, 
            {
                "description": "Questions related to packaging integrity and successful administration of product as assessed by the Principal Investigator.", 
                "measure": "Device Performance Evaluation", 
                "safety_issue": "No", 
                "time_frame": "Assessed at Day 1"
            }
        ], 
        "source": "Halscion, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Halscion, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}